Indeed, p38 MAPK inhibitors may even sensitize these lymphoma cells to apoptosis induced by Stx1, suggesting that p38 MAPK promotes survival and protects cells against Stx1-induced apoptosis [38]. Here, STX1A is linked to lymphoma.